
CAS: 2170729-29-8

AT-007
CAS:2170729-29-8
AT-007 is an orally active CNS penetrant Aldose Reductase inhibitor for the treatment of Galactosemia …
Formula:
C17H10F3N3O3S2
Purity:
99.36%
Color and Shape:
Solid
Molecular weight:
425.4
Ref: TM-T10393
1mg | 66.00 € | ||
5mg | 111.00 € | ||
10mg | 180.00 € | ||
25mg | 329.00 € | ||
50mg | 533.00 € | ||
100mg | 743.00 € | ||
1mL*10mM (DMSO) | 124.00 € |
Estimated delivery in United States, on Tuesday 15 Apr 2025

2-(4-Oxo-3-((5-(trifluoromethyl)benzo[d]thiazol-2-yl)methyl)-3,4-dihydrothieno[3,4-d]pyridazin-1-yl)acetic acid
CAS:2170729-29-8
Formula:
C17H10F3N3O3S2
Purity:
98%
Molecular weight:
425.4048
Ref: IN-DA01V487
1mg | 56.00 € | ||
5mg | 130.00 € | ||
10mg | 171.00 € | ||
50mg | 320.00 € |
Estimated delivery in United States, on Tuesday 15 Apr 2025

2-(4-Oxo-3-((5-(Trifluoromethyl)Benzo[D]Thiazol-2-Yl)Methyl)-3,4-Dihydrothieno[3,4-D]Pyridazin-1-Yl)Acetic Acid
CAS:2170729-29-8
Purity:
98%
Molecular weight:
425.4g/mol
Ref: 54-PC108452
1g | 2,045.00 € | ||
100mg | 503.00 € | ||
250mg | 594.00 € |
Estimated delivery in United States, on Monday 14 Apr 2025

2-(4-Oxo-3-((5-(trifluoromethyl)benzo[d]thiazol-2-yl)methyl)-3,4-dihydrothieno[3,4-d]pyridazin-1-yl)acetic acid
CAS:2170729-29-8
Purity:
98.0%
Molecular weight:
425.3999938964844
Ref: 10-F546907
1mg | To inquire | ||
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Wednesday 23 Apr 2025

AT-007
CAS:2170729-29-8
Please enquire for more information about AT-007 including the price, delivery time and more detailed …
Formula:
C17H10F3N3O3S2
Purity:
Min. 95%
Molecular weight:
425.4 g/mol
Ref: 3D-VLD72929
25mg | 727.00 € | ||
50mg | 1,097.00 € | ||
100mg | 1,526.00 € |
Estimated delivery in United States, on Tuesday 27 May 2025